Table 1. A Comparison of Demographic and Laboratory Data Between the Two Groups.
| Feature | Case (n = 41) | Control (n = 35) | P value |
|---|---|---|---|
| Age (years) | 34.07 ± 6.70 | 31.82 ± 5.57 | 0.121 |
| Gender (F/M) | 39/2 | 35/0 | 0.998 |
| BMI (kg/m2) | 27.84 ± 5.26 | 23.72 ± 3.01 | < 0.01 |
| Fat mass (%) | 31.74 ± 7.58 | 26.80 ± 6.42 | < 0.01 |
| Fat mass (kg) | 23.09 ± 9.89 | 16.85 ± 5.99 | < 0.01 |
| Waist circumstance (WC, cm) | 93.68 ± 12.09 | 87.94 ± 8.38 | 0.038 |
| Hip circumstance (HC, cm) | 103.86 ± 10.37 | 100.71 ± 6.73 | 0.152 |
| WC/HC | 0.95 ± 0.07 | 0.90 ± 0.005 | < 0.01 |
| Visceral adipose tissue | 9.53 ± 4.03 | 7.10 ± 2.40 | < 0.01 |
| Abdominal subcutaneous adipose tissue | 40.24 ± 6.57 | 35.33 ± 6.32 | < 0.01 |
| Systolic BP (mm Hg) | 120.10 ± 7.24 | 118.97 ± 7.36 | 0.471 |
| Diastolic BP (mm Hg) | 62.23 ± 5.80 | 60.70 ± 3.89 | 0.065 |
| FPG (mg/dL) | 90.68 ± 6.30 | 89.12 ± 7.68 | 0.780 |
| TSH (µIU/mL) | 14.55 ± 6.50 (median 7.64 ± 1.55) | 1.54 ± 0.82 (median 1.52 ± 0.78) | < 0.01 |
| FT4 (pmol/L) | 11.60 ± 2.68 | 14.15 ± 1.70 | < 0.01 |
| Anti-TPO (IU/mL) | 313.65 ± 358.69 | 2.42 ± 1.16 | < 0.01 |
| LDL (mg/dL) | 125.85 ± 31.73 | 104.39 ± 25.50 | < 0.01 |
| TG (mg/dL) | 105.90 ± 50.08 (median 93.50 ± 4.96) | 83.75 ± 27.17 (median 79.50 ± 2.50) | 0.026 |
| HDL (mg/dL) | 55.21 ± 15.40 | 57.32 ± 11.79 | 0.495 |
| EAT (mm) | 4.61 ± 0.06 | 4.51 ± 0.07 | 0.532 |